{
  "ptid_time": "011_S_4949_2012-09-19",
  "img_path": "/data/qiuhui/data/adni/images/011_S_4949/2012-09-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 17,264 mm³, 38.5% below the reference mean. With a Z-score of -0.88 (18.9th percentile), this represents normal volume ; hippocampal volume measures 6,009 mm³, 15.5% below the reference mean. With a Z-score of -1.43 (7.7th percentile), this represents mild atrophy; whole brain volume measures 986,185 mm³, 1.2% above the reference mean. With a Z-score of 0.15 (55.9th percentile), this represents normal volume ; entorhinal cortex volume measures 3,086 mm³, 16.0% below the reference mean. With a Z-score of -0.98 (16.3th percentile), this represents normal volume ; fusiform gyrus volume measures 17,061 mm³, 0.3% above the reference mean. With a Z-score of 0.03 (51.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,216 mm³, 20.6% below the reference mean. With a Z-score of -1.79 (3.7th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 78.1 years. Gender is Female. Education: 18 years. Handedness: Left. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 25.0. MoCA: 20.0. Logical Memory: 0.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.34 SUVR (significant elevated); Amyloid beta: 506.10 pg/mL (mild reduced); Total tau: 382.60 pg/mL (moderate elevated); Phosphorylated tau: 36.03 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The patient shows mild hippocampal atrophy and moderate middle temporal gyrus atrophy, along with biomarker evidence of amyloid pathology (elevated AV45, reduced Aβ, and elevated tau). Cognitive testing (MMSE 25, MoCA 20) suggests mild impairment, consistent with early cognitive decline.  \nDiagnosis: MCI (likely due to Alzheimer’s pathology)  \nConfidence: Medium (clinical and biomarker data align, but structural atrophy is not yet widespread enough for a dementia diagnosis)",
  "timestamp": "2025-07-25T23:02:31.355328"
}